Nuclear transcription factor-κB as a target for cancer drug development
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mercurio F, Manning A . NF-kB as a primary regulator of the stress response Oncogene 1999 18: 6163–6171
Sen R, Baltimore D . Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism Cell 1986 47: 921–928
Yamazaki S, Muta T, Takeshige K . A novel IκB protein, IκB-ζ, induced by proinflammatory stimuli, negatively regulates nuclear factor-κB in the nuclei J Biol Chem 2001 276: 27657–27662
Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S . Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation Genes Dev 1995 9: 2723–2735
Chen F, Ghosh G . Regulation of DNA binding by Rel/NF-kB transcription factors: structural views Oncogene 1999 18: 6845–6852
Pahl HL . Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 1999 18: 6853–6866
Busam K, Gieringer C, Freudenberg M, Hohmann HP . Staphylococcus aureus and derived exotoxins induce nuclear factor kappa B-like activity in murine bone marrow macrophages Infect Immunol 1992 60: 2008–2015
Bachelerie F, Alcami J, Arenzana-Seisdedos F, Virelizier JL . HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes Nature 1991 350: 709–712
Pahl HL, Baeuerle PA . Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B J Virol 1994 69: 1480–1484
Gabriel C, Justicia C, Camins A, Planas AM . Activation of nuclear factor-kappaB in the rat brain after transient focal ischemia Brain Res Mol Brain Res 1999 65: 61–69
Li C, Browder W, Kao RL . Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart Am J Physiol 1999 276: H543–552
Stein B, Kramer M, Rahmsdorf HJ, Ponta H, Herrlich P . UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells J Virol 1989 63: 4540–4544
Nishikawa M, Kakemizu N, Ito T, Kudo M, Kaneko T, Suzuki M, Udaka N, Ikeda H, Okubo T . Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo Am J Respir Cell Mol Biol 1999 20: 189–198
Hwang S, Ding A . Activation of NF-kappa B in murine macrophages by taxol Cancer Biochem Biophys 1995 14: 265–272
Post A, Holsboer F, Behl C . Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants J Neurosci 1989 18: 8236–8246
Rensing-Ehl A, Hess S, Ziegler-Heitbrock HW, Riethmuller G, Engelmann H . Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production J Inflam 1995 45: 161–174
Bertrand F, Philippe C, Antoine PJ, Baud L, Groyer A, Capeau J, Cherqui G . Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway J Biol Chem 1995 270: 24435–24441
Li J, Brasier AR . Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes Mol Endocrinol 1996 10: 252–264
Smith CS, Shearer WT . Activation of NF-kappa B and immunoglobulin expression in response to platelet-activating factor in a human B cell line Cell Immunol 1994 155: 292–303
Mutoh H, Ishii S, Izumi T, Kato S, Shimizu T . Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B Biochem Biophys Res Commun 1994 205: 1137–1142
Schreck R, Rieber P, Baeuerle PA . Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J 1991 10: 2247–2258
Canty TG Jr, Boyle EM Jr, Farr A, Morgan EN, Verrier ED, Pohlman TH . Oxidative stress induces NF-kappaB nuclear translocation without degradation of IkappaBalpha Circulation 1999 100 (19 Suppl.): II361–II364
Raju U, Gumin GJ, Noel F, Tofilon PJ . IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells Int J Rad Biol 1998 74: 617–624
Singh S, Darnay BG, Aggarwal BB . Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation J Biol Chem 1996 271: 31049–31054
Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF . Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha Cell 1996 86: 787–798
Digicaylioglu M, Lipton SA . Erythropoietin-mediated neuroprotection involves cross-talk between JAK2 and NF-kB signalling cascades Nature 2001 412: 641–647
Karin M . How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex Oncogene 1999 18: 6867–6874
Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM . Severe liver degeneration in mice lacking the IkappaB kinase 2 gene Science 1999 284: 321–325
Senftleben U, Li ZW, Baud V, Karin M . IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis Immunity 2001 14: 217–230
Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M . Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway Science 2001 293: 1495–1499
Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, Karin M . Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase Science 1999 284: 316–320
Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, Sanjo H, Yoshikawa K, Terada N, Akira S . Limb and skin abnormalities in mice lacking IKKalpha Science 1999 284: 313–316
Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, Marcu KB . Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition J Biol Chem 2001 276: 18579–18590
Rothwarf DM, Zandi E, Natoli G, Karin M . IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex Nature 1998 395: 297–300
Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israel A, Rajewsky K, Pasparakis M . NEMO/IKK gamma-deficient mice model incontinentia pigmenti Mol Cell 2000 5: 981–992
Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S . IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases Int Immunol 1999 11: 1357–1362
Peters RT, Liao SM, Maniatis T . IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex Mol Cell 2000 5: 513–522
Nomura F, Kawai T, Nakanishi K, Akira S . NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation Genes Cells 2000 5: 191–202
Malinin NL, Boldin MP, Kovalenko AV, Wallach D . MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1 Nature 1997 385: 540–544
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M . A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB Nature 1997 388: 548–557
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A . IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation Science 1997 278: 860–866
Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M . The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation Cell 1997 91: 243–252
Zandi E, Chen Y, Karin M . Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate Science 1998 281: 1360–1363
Sanz L, Sanchez P, Lallena MJ, Diaz-Meco MT, Moscat J . The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation EMBO J 1999 18: 3044–3053
Diaz-Meco MT, Berra E, Municio MM, Sanz L, Lozano J, Dominguez I, Diaz-Golpe V, Lain de Lera MT, Alcami J, Paya CV . A dominant negative protein kinase C zeta subspecies blocks NF-kappaB activation Mol Cell Biol 1993 13: 4770–4775
Chen CC, Sun YT, Chen JJ, Chiu KT . TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway J Immunol 2000 165: 2719–2728
Vertegaal AC, Kuiperij HB, Yamaoka S, Courois G, van der Eb AJ, Zantema A . Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U20S cells Cell Signal 2000 12: 759–768
McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, Benito A, Li Q, Chen S, Chen FF, Yamaoka S, Verma IM, Mak TW, Nunez G . Bimp1, a MAGUK family member linking protein kinase C activation to Bc110-mediated NF-kappaB induction J Biol Chem 2001 276: 30589–30597
Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, Stabel S, Tarakhovsky A . Immunodeficiency in protein kinase cbeta-deficient mice Science 1996 273: 788–791
Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC . Protein kinase C-theta participates in NK-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta Mol Cell Biol 2000 20: 2933–2940
Bauer B, Krumbock N, Fresser F, Hochholdinger F, Spitaler M, Simm A, Uberall F, Schraven B, Baier G . Complex formation and cooperation of protein kinase C theta and Akt1/protein kinase B alpha in the NF-kappa B transactivation cascade in Jurkat T cells J Biol Chem 2001 276: 31627–31634
Vancurova I, Miskolci V, Davidson D . NF-kappa B activation in tumor necrosis factor alpha-stimulated neutrophils is mediated by protein kinase Cdelta. Correlation to nuclear Ikappa Balpha J Biol Chem 2001 276: 19746–19752
Diaz-Guerra MJ, Bodelon OG, Velasco M, Whelan R, Parker PJ, Bosca L . Up-regulation of protein kinase C-epsilon promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells J Biol Chem 1996 271: 32028–32033
Li JD, Feng W, Gallup M, Kim JH, Gum J, Kim Y, Basbaum C . Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells Proc Natl Acad Sci USA 1998 95: 5718–5723
Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR . Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B Proc Natl Acad Sci USA 1994 91: 6288–6292
Belich MP, Salmeron A, Johnston LH, Ley SC . TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105 Nature 1999 397: 363–368
Zhao Q, Lee FS . Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta J Biol Chem 1999 274: 8355–8358
Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, Liao W, Chen Z, Liu Z, Su B . The essential role of MEKK3 in TNF-induced NF-kappaB activation Nat Immunol 2001 7: 620–624
Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K, Kaneko Y, Nimura Y, Motoyama N, Ikeda K, Karin M, Nakanishi M . NAK is an IkappaB kinase-activating kinase Nature 2000 404: 778–782
Pomerantz JL, Baltimore D . NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase EMBO J 1999 18: 6694–6704
Bonnard M, Mirtsos C, Suzuki S, Graham K, Huang J, Ng M, Itie A, Wakeham A, Shahinian A, Henzel WJ, Elia AJ, Shillinglaw W, Mak TW, Cao Z, Yeh WC . Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription EMBO J 2000 19: 4976–4985
Reddy SA, Huang JH, Liao WS . Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation J Biol Chem 1997 272: 29167–29173
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB . NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase Nature 1999 401: 82–85
Hehner SP, Hofmann TG, Ushmorov A, Dienz O, Wing-Lan Leung I, Lassam N, Scheidereit C, Droge W, Schmitz ML . Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex Mol Cell Biol 2000 20: 2556–2568
Hu MC, Wang Yp, Qiu WR, Mikhail A, Meyer CF, Tan TH . Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinase Oncogene 1999 18: 5514–5524
Wang W, Zhou G, Hu MC, Yao Z, Tan TH . Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction J Biol Chem 1997 272: 22771–22775
Wang W, Zhou G, Hu MC, Yao Z, Tan TH . Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction J Biol Chem 1997 272: 22771–22775
Finco TS, Baldwin AS Jr . Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1 J Biol Chem 1993 268: 17676–17679
Troppmair J, Hartkamp J, Rapp UR . Activation of NF-kappa B by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade Oncogene 1998 17: 685–690
Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH . Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1 J Biol Chem 2000 275: 19693–19699
Petro JB, Rahman SM, Ballard DW, Khan WN . Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement J Exp Med 2000 191: 1745–1754
Zhong H, Voll RE, Ghosh S . Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 Mol Cell 1998 1: 661–671
Zhong H, Su Yang H, Erdjument-Bromage H, Tempst P, Ghosh S . The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism Cell 1997 89: 413–424
Li YL, Guo FK, Wu SG . Effects of antisense IRAK-2 oligonucleotides on PGI2 release induced by IL-1 and TNF Acta Pharmacol Sin 2000 21: 646–648
Jefferies C, Bowie A, Brady G, Cooke EL, Li X, O'Neill LA . Transactivation by the p65 subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1 Mol Cell Biol 2001 21: 4544–4552
Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z . IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family J Biol Chem 1999 274: 19403–19410
Manna SK, Sah NK, Aggarwal BB . Protein tyrosine kinase p561ck is required for ceramide-induced by not TNF-induced cellular responses: effect on activation of NF-kB, AP-1, JNK and apoptosis J Biol Chem 2000 275: 13297–13306
Manna SK, Aggarwal BB . Differential requirement for p561ck in HIV-TAT vs. TNF-induced cellular responses: effects on NF-kB, AP-1, JNK and apoptosis J Immunol 2000 164: 5166
Chen F, Demers LM, Vallyathan V, Ding M, Lu Y, Castranova V, Shi X . Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK/ERK kinase 1 in macrophages J Biol Chem 1999 274: 20307–20312
Sha WC, Liou HC, Tuomanen EI, Baltimore D . Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses Cell 1995 80: 321–330
Grumont RJ, Rourke IJ, O'Reilly LA, Strasser A, Miyake K, Sha W, Gerondakis S . B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells J Exp Med 1998 187: 663–674
Snapper CM, Zelazowski P, Rosas FR, Kehry MR, Tian M . Baltimore D, Sha WC. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching J Immunol 1996 156: 183–191
Beg AA, Baltimore D . An essential role for NF-kappaB in preventing TNF-alpha-induced cell death Science 1996 274: 782–784
Doi TS, Takahashi T, Taguchi O, Azuma T, Obata Y . NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses J Exp Med 1997 185: 953–961
Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S . Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression Genes Dev 1995 9: 1965–1977
Grumont RJ, Rourke IJ, Gerondakis S . Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis Genes Dev 1999 13: 400–411
Gerondakis S, Grumont R, Rourke I, Grossmann M . The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation Curr Opin Immunol 1998 10: 353–359
Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlinck JY, Grumont RJ . Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor Proc Natl Acad Sci USA 1996 93: 3405–3409
Grigoriadis G, Zhan Y, Grumont RJ, Metcalf D, Handman E, Cheers C, Gerondakis S . The Rel subunit of NF-kappaB-like transcription factors is a positive and negative regulator ofmacrophage gene expression: distinct roles for Rel in different macrophage populations EMBO J 1996 15: 7099–7107
Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME . Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel Oncogene 2001 20: 7098–7103
Caamano JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suarez C, Snapper CM, Bravo R . Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses J Exp Med 1998 187: 185–196
Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U . Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture J Exp Med 1998 187: 147–159
Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R . Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts Oncogene 1999 18: 6888–6895
Beg AA, Sha WC, Bronson RT, Baltimore D . Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice Genes Dev 1995 9: 2736–2746
Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, Chen CH, Rosen CA, Stewart CL . IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice Mol Cell Biol 1996 16: 2341–2349
Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M . The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis J Exp Med 1999 189: 1839–1845
Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV . Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice Immunity 1999 10: 421–429
Sharma HW, Narayanan R . The NF-kappaB transcription factor in oncogenesis Anticancer Res 1996 16: 589–596
Waddick KG, Uckun FM . Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target Biochem Pharmacol 1999 57: 9–17
Dong G, Chen Z, Kato T, Van Waes C . The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma Cancer Res 1999 59: 3495–3504
Wang TH, Wang HS . p53, apoptosis and human cancers J Formos Med Assoc 1996 95: 509–521
Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM . Suppression of TNF-alpha-induced apoptosis by NF-kappaB Science 1996 274: 787–789
Giri DK, Aggarwal BB . Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates J Biol Chem 1998 273: 14008–14014
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr . Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth Mol Cell Biol 1997 17: 3629–3639
Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr . Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB Nat Med 1999 5: 412–417
Wang CY, Guttridge DC, Mayo MW, Baldwin AS Jr . NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis Mol Cell Biol 1999 19: 5923–5929
Kalgutkar AS, Zhao Z . Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents Curr Drug Targets 2001 2: 79–106
Marrogi A, Pass HI, Khan M, Metheny-Barlow LJ, Harris CC, Gerwin BI . Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2: in vitro antiproliferative effects of a COX-2 inhibitor Cancer Res 2000 60: 3696–3700
Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP . Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors Cancer Res 2000 60: 4044–4048
Noguchi Y, Makino T, Yoshikawa T, Nomura K, Fukuzawa K, Matsumoto A, Yamada T . The possible role of TNF-alpha and IL-2 in inducing tumor-associated metabolic alterations Surg Today 1996 26: 36–41
Tomimatsu S, Ichikura T, Mochizuki H . Significant correlation between expression of interleukin-1alpha and liver metastasis in gastric carcinoma Cancer 2001 91: 1272–1276
Klotz T, Bloch W, Jacobs G, Niggemann S, Engelmann U, Addicks K . Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer Urology 1999 54: 416–419
Dong Z . Nemeth JA. Cher ML. Palmer KC. Bright RC. Fridman R. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells Int J Cancer 2001 93: 507–515
Pacheco MM, Nishimoto IN, Mourao Neto M, Mantovani EB, Brentani MM . Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis Int J Biol Markers 2001 16: 62–68
Strieter RM . Chemokines: not just leukocyte chemoattractants in the promotion of cancer Nat Immunol 2001 2: 285–286
Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR . Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 2001 61: 4961–4965
Palmer K, Hitt M, Emtage PC, Gyorffy S, Gauldie J . Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity Gene Ther 2001 8: 282–290
Loch T, Michalski B, Mazurek U, Graniczka M . Vascular endothelial growth factor (VEGF) and its role in neoplastic processes Postepy Hig Med Dosw 2001 55: 257–274
Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K . Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin Cancer Res 2000 6: 3282–3289
Oyama T, Sakuta T, Matsushita K, Maruyama I, Nagaoka S, Torii M . Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture J Periodontol 2000 71: 1546–1553
Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, Palotie A, Joukov V, Alitalo K . Genomic organization of human and mouse genes for vascular endothelial growth factor C J Biol Chem 1997 272: 25176–25183
Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV . Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages J Exp Med 1990 171: 35–47
Collart MA, Baeuerle P, Vassalli P . Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B Mol Cell Biol 1990 10: 1498–1506
Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T . NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene J Immunol 1994 153: 2052–2063
van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, van der Saag PT . 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter J Biol Chem 1994 269: 6185–6192
Whelan J, Ghersa P, Hooft van Huijsduijnen R, Gray J, Chandra G, Talabot F, DeLamarter JF . An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription Nucleic Acids Res 1991 19: 2645–2653
Iademarco MF, McQuillan JJ, Rosen GD, Dean DC . Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1) J Biol Chem 1992 267: 16323–16329
Koong AC, Chen EY, Giaccia AJ . Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues Cancer Res 1994 54: 1425–1430
Folkman J . Diagnostic and therapeutic applications of angiogenesis research C R Acad Sci III 1993 316: 909–918
Beg AA, Baltimore D . An essential role for NF-kappaB in preventing TNF-alpha-induced cell death Science 1996 274: 782–784
Wang CY, Mayo MW, Baldwin AS Jr . TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB Science 1996 274: 784–787
Jimi E, Nakamura I, Ikebe T, Akiyama S, Takahashi N, Suda T . Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1 J Biol Chem 1998 273: 8799–8805
Bakker TR, Reed D, Renno T, Jongeneel CV . Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis Int J Cancer 1999 80: 320–323
McDade TP, Perugini RA, Vittimberga FJ Jr, Callery MP . Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells Surgery 1999 126: 371–377
Sumitomo M, Tachibana M, Ozu C, Asakura H, Murai M, Hayakawa M, Nakamura H, Takayanagi A, Shimizu N . Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression Hum Gene Ther 1999 10: 37–47
Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE . Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer J Clin Invest 1997 100: 2952–2960
Arsura M, Wu M, Sonenshein GE . TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha Immunity 1996 5: 31–40
Lee H, Wu M, La Rosa FA, Duyao MP, Buckler AJ, Sonenshein GE . Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells Curr Top Microbiol Immunol 1995 194: 247–255
Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW . Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappaB J Exp Med 1997 185: 1897–1907
Esslinger CW, Jongeneel CV, MacDonald HR . Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation Mol Immunol 1998 35: 847–852
Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C, Rossi AG . NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro J Biol Chem 1999 274: 4309–4318
von Knethen A, Callsen D, Brune B . Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression J Immunol 1999 163: 2858–2866
Bales KR, Du Y, Dodel RC, Yan GM, Hamilton-Byrd E, Paul SM . The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation Brain Res Mol Brain Res 1998 57: 63–72
Maggirwar SB, Sarmiere PD, Dewhurst S, Freeman RS . Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons J Neurosci 1998 18: 10356–10365
Erl W, Hansson GK, de Martin R, Draude G, Weber KS, Weber C . Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells Circ Res 1999 84: 668–677
Abbadie C, Kabrun N, Bouali F, Smardova J, Stehelin D, Vandenbunder B, Enrietto PJ . High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro Cell 1993 75: 899–912
Dumont A, Hehner SP, Hofmann TG, Ueffing M, Droge W, Schmitz ML . Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB Oncogene 1999 18: 747–757
Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR . DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1 Mol Cell 1998 1: 543–551
Qin ZH, Chen RW, Wang Y, Nakai M, Chuang DM, Chase TN . Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum J Neurosci 1999 19: 4023–4033
Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M . NF-kappaB is activated and promotes cell death in focal cerebral ischemia Nat Med 1999 5: 554–559
DeMeester SL, Qiu Y, Buchman TG, Hotchkiss RS, Dunnigan K, Karl IE, Cobb JP . Nitric oxide inhibits stress-induced endothelial cell apoptosis Crit Care Med 1998 26: 1500–1509
Chan H, Bartos DP, Owen-Schaub LB . Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment Mol Cell Biol 1999 19: 2098–2108
Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ . Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes J Biol Chem 1999 274: 37957–37964
Stehlik C, de Martin R, Binder BR, Lipp J . Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B Biochem Biophys Res Commun 1998 243: 827–832
Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr . NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1 Mol Cell Biol 1999 19: 5785–5799
Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition Mol Cell Biol 1999 19: 2690–2698
Bash J, Zong WX, Gelinas C . c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition Mol Cell Biol 1997 17: 6526–6536
Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ, Bedi A . p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300 Cancer Res 1998 58: 4531–4536
Yang JP, Hori M, Takahashi N, Kawabe T, Kato H, Okamoto T . NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2 Oncogene 1999 18: 5177–5186
Miyamoto S, Chiao PJ, Verma IM . Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines Mol Cell Biol 1994 14: 3276–3282
Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE . Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells EMBO J 1996 15: 4682–4690
Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dorken B . High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed–Sternberg cells Blood 1996 87: 4340–4347
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B . Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells J Clin Invest 1997 100: 2961–2969
Wood KM, Roff M, Hay RT . Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB Oncogene 1998 16: 2131–2139
O'Connell MA, Cleere R, Long A, O'Neill LA, Kelleher D . Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78 J Biol Chem 1995 270: 7399–7404
Mori N, Nunokawa Y, Yamada Y, Ikeda S, Tomonaga M, Yamamoto N . Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells Blood 1999 94: 2862–2870
Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C . Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells Leukemia 2000 14: 399–402
FitzGerald MJ, Webber EM, Donovan JR, Fausto N . Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration Cell Growth Differ 1995 6: 417–427
Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, Brenner DA . NFkappaB prevents apoptosis and liver dysfunction during liver regeneration J Clin Invest 1998 101: 802–811
Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS, Sonenshein GE . Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells Mol Cell Biol 2000 20: 5381–5391
Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M, Fusco A . Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression Oncogene 1997 15: 1987–1994
Wang W, Abbruzzese JL, Evans DB, Chiao PJ . Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA Oncogene 1999 18: 4554–4563
Want W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ . The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells Clin Cancer Res 1999 5: 119–127
Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD . Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells in inhibited by ibuprofen Oncogene 1999 18: 7389–7394
Sumitomo M, Tachibana M, Nakashima J, Murai M, Miyajima A, Kimura F, Hayakawa M, Nakamura H . An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells J Urol 1999 161: 674–679
Shattuck-Brandt RL, Richmond A . Enhanced degradation ofI-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells Cancer Res 1997 57: 3032–3039
Ondrey FG, Dong G, Sunwoo J, Chen Z, Wolf JS, Crowl-Bancroft CV, Mukaida N, Van Waes C . Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines Mol Carcinog 1999 26: 119–129
Cadoret A, Bertrand F, Baron-Delage S, Levy P, Courtois G, Gespach C, Capeau J, Cherqui G . Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells Oncogene 1997 14: 1589–1600
Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS . Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2 Blood 1999 93: 3044–2052
Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V . The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines Biochem Pharmacol 1994 47: 145–149
Batra RK, Guttridge DC, Brenner DA, Dubinett SM, Baldwin AS, Boucher RC . IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death Am J Respir Cell Mol Biol 1999 21: 238–245
Mukhopadhyay T, Roth JA, Maxwell SA . Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma Oncogene 1995 11: 999–1003
Yamagishi N, Miyakoshi J, Takebe H . Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells Int J Radiat Biol 1997 72: 157–162
Zhou G, Kuo MT . NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells J Biol Chem 1997 272: 15174–15183
Rayet B, Gelinas C . Aberrant rel/nfkb genes and activity in human cancer Oncogene 1999 18: 6938–6947
Mathew S, Murty VV, Dalla-Favera R, Chaganti RS . Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization Oncogene 1993 8: 191–193
Motokura T, Arnold A . PRAD1/cyclin D1 proto-oncogene:genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint Genes Chromosomes Cancer 1993 7: 89–95
Trecca D, Guerrini L, Fracchiolla NS, Pomati M, Baldini L, Maiolo AT, Neri A . Identification of a tumor-associated mutant form of the NF-kappaB RelA gene with reduced DNA-binding and transactivating activities Oncogene 1997 14: 791–799
Barth TF, Dohner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M, Lichter P, Moller P, Bentz M . Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract Blood 1998 91: 4321–4330
Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N, Offit K, Chaganti RS . REL proto-oncogene is frequently amplified in extranodal diffuse large cell lyphoma Blood 1996 87: 25–29
Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC, Popplewell L, Offit K, Jhanwar SC, Chaganti RS . Chromosomal and gene amplification in diffuse large B-cell lymphoma Blood 1998 92: 234–240
Joos S, Otano-Joos MI, Ziegler S, Bruderlein S, du Manoir S, Bentz M, Moller P, Lichter P . Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene Blood 1996 87: 1571–1578
Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ . Alterations at the rel locus in human lymphoma Oncogene 1991 6: 1235–1241
Liptay S, Schmid RM, Perkins ND, Meltzer P, Altherr MR, McPherson JD, Wasmuth JJ, Nabel GJ . Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2 Genomics 1992 13: 287–292
Ferrier R, Nougarede R, Doucet S, Kahn-Perles B, Imbert J, Mathieu-Mahul D . Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105 Oncogene 1999 18: 995–1005
Fracchiolla NS, Lombardi L, Salina M, Migliazza A, Baldini L, Berti E, Cro L, Polli E, Maiolo AT, Neri A . Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies Oncogene 1993 8: 2839–2845
Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang CC, Antonacci R, Fracchiolla NS, Ciana P, Maiolo AT, Neri A . Heterogeneous chromosomal aberrations generate 3′ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies Blood 1994 84: 3850–3860
Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R . B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50 Cell 1991 67: 1075–1087
Neri A, Fracchiolla NS, Roscetti E, Garatti S, Trecca D, Boletini A, Perletti L, Baldini L, Maiolo AT, Berti E . Molecular analysis of cutaneous B- and T-cell lymphomas Blood 1995 86: 3160–3172
Thakur S, Lin HC, Tseng WT, Kumar S, Bravo R, Foss F, Gelinas C, Rabson AB . Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells Oncogene 1994 9: 2335–2344
Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, Bours V . Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells Oncogene 1995 11: 1835–1841
Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT . Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha Oncogene 1999 18: 3063–3070
Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dorken B, Scheidereit C . Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed–Sternberg cells Oncogene 1999 18: 943–953
Epinat JC, Gilmore TD . Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway Oncogene 1999 18: 6896–6909
D'Acquisto F, Ialenti A, Ianaro A, Di Vaio R, Carnuccio R . Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw Gene Ther 2000 7: 1731–1737
Gerbes AL, Vollmar AM, Kiemer AK, Bilzer M . The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver Hepatology 1998 28: 1309–1317
Manna SK, Aggarwal BB . Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13 J Biol Chem 1998 273: 33333–33341
Shumilla JA, Wetterhahn KE, Barchowsky A . Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism Arch Biochem Biophys 1998 349: 356–362
Yang JP, Merin JP, Nakano T, Kato T, Kitade Y, Okamoto T . Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro FEBS Lett 1995 361: 89–96
Fiedler MA, Wernke-Dollries K, Stark JM . Inhibition of viral replication reverses respiratory syncytial virus-induced NF-kappaB activation and interleukin-8 gene expression in A549 cells J Virol 1996 70: 9079–9082
Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone DP, Gabrilovich DI . Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells J Immunol 1998 160: 1224–1232
Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP . Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo Blood 1998 92: 4150–4166
Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB . Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B Proc Natl Acad Sci USA 1996 93: 9090–9095
Delgado M, Munoz-Elias EJ, Kan Y, Gozes I, Fridkin M, Brenneman DE, Gomariz RP, Ganea D . Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun J Biol Chem 1998 273: 31427–31436
Russo SM, Tepper JE, Baldwin AS Jr, Liu R, Adams J, Elliott P, Cusack JC Jr . Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB Int J Radiat Oncol Biol Phys 2001 50: 183–193
Palombella VJ, Rando OJ, Goldberg AL, Maniatis T . The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B Cell 1994 78: 773–785
Grisham MB, Palombella VJ, Elliott PJ, Conner EM, Brand S, Wong HL, Pien C, Mazzola LM, Destree A, Parent L, Adams J . Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome Methods Enzymol 1999 300: 345–363
Jobin C, Hellerbrand C, Licato LL, Brenner DA, Sartor RB . Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors Gut 1998 42: 779–787
Fenteany G, Schreiber SL . Lactacystin, proteasome function, and cell fate J Biol Chem 1998 273: 8545–8548
Cusack JC Jr, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J, Baldwin AS Jr . Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition Cancer Res 2001 61: 3535–3540
Yaron A, Gonen H, Alkalay I, Hatzubai A, Jung S, Beyth S, Mercurio F, Manning AM, Ciechanover A, Ben-Neriah Y . Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase EMBO J 1997 16: 6486–6494
Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O'Keefe SJ, O'Neill EA . Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B EMBO J 1994 13: 861–870
Singh S, Natarajan K, Aggarwal BB . Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents J Immunol 1996 157: 4412–4420
Shrivastava A, Manna SK, Ray R, Aggarwal BB . Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors J Virol 1998 72: 9722–9728
Pahl HL, Krauss B, Schulze-Osthoff K, Decker T, Traenckner EB, Vogt M, Myers C, Parks T, Warring P, Muhlbacher A, Czernilofsky AP, Baeuerle PA . The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB J Exp Med 1996 183: 1829–1840
Manna SK, Aggarwal BB . IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis J Immunol 1998 161: 2863–2872
Singh S, Aggarwal BB . Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B J Biol Chem 1995 270: 10631–10639
Frantz B, O'Neill EA . The effect of sodium salicylate and aspirin on NF-kappa B Science 1995 270: 2017–2019
Kopp E, Ghosh S . Inhibition of NF-kappa B by sodium salicylate and aspirin Science 1994 265: 956–959
Palayoor ST, Bump EA, Calderwood SK, Bartol S, Coleman CN . Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells Clin Cancer Res 1998 4: 763–771
Katsuyama K, Shichiri M, Marumo F, Hirata Y . NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha Arterioscler Thromb Vasc Biol 1998 18: 1796–1802
Matthews JR, Botting CH, Panico M, Morris HR, Hay RT . Inhibition of NF-kappaB DNA binding by nitric oxide Nucleic Acids Res 1996 24: 2236–2242
Spiecker M, Liao JK . Assessing induction of I kappa B by nitric oxide Methods Enzymol 1999 300: 374–388
Rossi A, Elia G, Santoro MG . Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation Proc Natl Acad Sci USA 1997 94: 746–750
Chaturvedi MM, Kumar A, Darnay BG, Chainy GB, Agarwal S, Aggarwal BB . Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation J Biol Chem 1997 272: 30129–30134
Schesser K, Spiik AK, Dukuzumuremyi JM, Neurath MF, Pettersson S, Wolf-Watz H . The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity Mol Microbiol 1998 28: 1067–1079
Ji C, Kozak KR, Marnett LJ . IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal J Biol Chem 2001 276: 18223–18228
May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S . Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex Science 2000 289: 1550–1554
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M . Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 1995 270: 286–290
Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H . Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis J Biol Chem 1996 271: 19612–19616
Ehrlich LC, Hu S, Peterson PK, Chao CC . IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation Neuroreport 1998 9: 1723–1736
Lentsch AB, Shanley TP, Sarma V, Ward PA . In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13 J Clin Invest 1997 100: 2443–2448
Pahl HL . Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 1999 18: 6853–6866
Siebenlist U, Franzoso G, Brown K . Structure, regulation and function of NF-kappa B Annu Rev Cell Biol 1994 10: 405–455
Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA . Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells J Exp Med 1992 175: 1181–1194
Singh S, Aggarwal BB . Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) J Biol Chem 1995 270: 24995–25000
Cho S, Urata Y, Iida T, Goto S, Yamaguchi M, Sumikawa K, Kondo T . Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells Biochem Biophys Res Commun 1998 253: 104–108
Staal FJ, Roederer M, Raju PA, Anderson MT, Ela SW, Herzenberg LA, Herzenberg LA . Antioxidants inhibit stimulation of HIV transcription AIDS Res Hum Retroviruses 1993 9: 299–306
Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J . Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence J Biol Chem 1995 270: 14255–14258
Pieper GM, Riaz-ul-Haq . Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C J Cardiovasc Pharmacol 1997 30: 528–532
Shoji S, Furuishi K, Ogata A, Yamataka K, Tachibana K, Mukai R, Uda A, Harano K, Matsushita S, Misumi S . An allosteric drug, o,o′-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B Biochem Biophys Res Commun 1998 249: 745–753
Bentires-Alj M, Hellin AC, Ameyar M, Chouaib S, Merville MP, Bours V . Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs Cancer Res 1999 59: 811–815
Jobin C, Panja A, Hellerbrand C, Iimuro Y, Didonato J, Brenner DA, Sartor RB . Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells J Immunol 1998 160: 410–418
Van Antwerp DJ, Verma IM . Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required Mol Cell Biol 1996 16: 6037–6045
Abu-Amer Y, Dowdy SF, Ross FP, Clohisy JC, Teitelbaum SL . TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis J Biol Chem 2001 276: 30499–30503
Chen LF, Fischle W, Verdin E, Greene WC . Duration of nuclear NF-kappaB action regulated by reversible acetylation Science 2001 293: 1653–1657
Chapman NR, Perkins ND . Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1 J Biol Chem 2000 275: 4719–4725
Cogswell PC, Mayo MW, Baldwin AS Jr . Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-alpha-induced NF-kappa B1 transcription J Exp Med 1997 185: 491–497
Yang JP, Hori M, Sanda T, Okamoto T . Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor J Biol Chem 1999 274: 15662–15670
Diaz-Meco MT, Lallena MJ, Monjas A, Frutos S, Moscat J . Inactivation of the inhibitory kappaB protein kinase/nuclear factorkappaB pathway by Par-4 expression potentiates tumor necrosisfactor alpha-induced apoptosis J Biol Chem 1999 274: 19606–19612
Chakraborty M, Qiu SG, Vasudevan KM, Rangnekar VM . Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression Cancer Res 2001 61: 7255–7263
Camandola S, Mattson MP . Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression J Neurosci Res 2000 61: 134–139
Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH . E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways Mol Cell 1999 4: 771–781
Webster GA, Perkins ND . Transcriptional cross talk between NF-kappaB and p53 Mol Cell Biol 1999 19: 3485–3495
Ikeda A, Sun X, Li Y, Zhang Y, Eckner R, Doi TS, Takahashi T, Obata Y, Yoshioka K, Yamamoto K . p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53 Biochem Biophys Res Commun 2000 272: 375–379
Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin AS Jr . Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras Science 1997 278: 1812–1815
Chen E, Li CC . Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase Biochem Biophys Res Commun 1998 249: 728–734
Ryan KM, Ernst MK, Rice NR, Vousden KH . Role of NF-kappaB in p53-mediated programmed cell death Nature 2000 404: 892–897
Hsu H, Shu HB, Pan MG, Goeddel DV . TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways Cell 1996 84: 299–308
Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV . TRAF6 is a signal transducer for interleukin-1 Nature 1996 383: 443–446
Rothe M, Xiong J, Shu HB, Williamson K, Goddard A, Goeddel DV . I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction Proc Natl Acad Sci USA 1996 93: 8241–8246
Song HY, Regnier CH, Kirschning CJ, Goeddel DV, Rothe M . Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2 Proc Natl Acad Sci USA 1997 94: 9792–9796
Jang IK, Lee ZH, Kim YJ, Kim SH, Kwon BS . Human 4–1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B Biochem Biophys Res Commun 1998 242: 613–620
Ling L, Cao Z, Goeddel DV . NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176 Proc Natl Acad Sci USA 1998 95: 3792–3797
Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M . Identification and characterization of an IkappaB kinase Cell 1997 90: 373–383
Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV . IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK Science 1997 278: 866–869
Baeuerle PA, Baichwal VR . NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules Adv Immunol 1997 65: 111–137
Maniatis T . A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways Genes Dev 1999 13: 505–510
Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D . Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B Nature 1995 376: 167–170